| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/21/2002 | US6391892 Naphthyl pharmaceutical compounds |
| 05/21/2002 | US6391875 Pharmaceutically active morpholinol |
| 05/21/2002 | US6391309 Composition made from plant matter enriched in at least two phytochemicals selected from isoflavones, lignans, saponins, sapogenins, catechins and phenolic acids; therapeutic treatment for female disorders |
| 05/21/2002 | US6391308 Method of preparing and using isoflavones for the treatment of blood related illnesses |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
| 05/16/2002 | WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors |
| 05/16/2002 | WO2002038175A1 Vaccines with enhanced immune response and methods for their preparation |
| 05/16/2002 | WO2002038159A1 Remedies for endometrial hyperplasia |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2001088098A3 Fertilization of aged oocytes |
| 05/16/2002 | WO2001087287A3 Use of pyrazole derivatives for treating infertility |
| 05/16/2002 | WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE |
| 05/16/2002 | WO2001085144A3 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001047928A3 Imidazo 1,3,5 triazinones and the use thereof |
| 05/16/2002 | WO2001007434A3 Indole derivatives and their use as 5ht2a ligands |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception |
| 05/16/2002 | US20020058649 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058072 Use of iodide salt as an aphrodisiac |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/16/2002 | US20020058035 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 05/16/2002 | DE10054641A1 Verwendung einer Zubereitung von Cimicifuga racemosa Use of a preparation of Cimicifuga racemosa |
| 05/16/2002 | CA2428103A1 Vaccines with enhanced immune response and methods for their preparation |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/15/2002 | EP1205185A1 Uterine contraction inhibitors |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204656A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204655A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP1204416A1 Carnitine analogues as topical, microbicidal spermicides |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0963201B1 Transdermal application of naturally occurring steroid hormones |
| 05/15/2002 | EP0865278B1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 05/15/2002 | EP0805813B1 Tricyclic vasopressin antagonists |
| 05/15/2002 | EP0778833B1 Endothelin receptor antagonists |
| 05/15/2002 | EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same |
| 05/15/2002 | EP0733621B1 Novel imidazole derivative and process for producing the same |
| 05/15/2002 | CN1349538A Cyclocarbamate and cyclic amide derivatives |
| 05/15/2002 | CN1349537A Cyclic urea and cyclic amide derivatives |
| 05/15/2002 | CN1349536A Thienopyrimidine compounds, their production and use |
| 05/15/2002 | CN1349535A Bicyclic heteroaromatic compounds useful as LH agonists |
| 05/15/2002 | CN1349531A Cyanopyrroles as progesterone receptor agonists |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349518A 2,1-benzisothiazoline 2,2-dioxydes |
| 05/15/2002 | CN1349517A Cyclocarbamate derivatives as progesterone receptor modulators |
| 05/15/2002 | CN1349516A Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 05/15/2002 | CN1349511A Benzimidazolrone and analogues, and the use as ligand of progesterone |
| 05/15/2002 | CN1349508A Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 05/15/2002 | CN1349500A 3,3-substituted indoline derivatives |
| 05/15/2002 | CN1349499A Thio-oxindole derivatives |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349422A Contraceptive compositions containing cyclic carbramates and amide derivatives |
| 05/15/2002 | CN1349417A Contraceptive compositions containing 3,3-substituted indoline derivatives and use thereof |
| 05/15/2002 | CN1349416A Contraceptive compositions contaiing indoline derivatives and progestational agents |
| 05/15/2002 | CN1349415A Contraceptive compositions contaiing antiprogesting and progestinic |
| 05/15/2002 | CN1349414A Contraceptive compositions containing 2,1-benzisothiazoline 2,2-dioxides and progestations |
| 05/15/2002 | CN1349413A Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
| 05/15/2002 | CN1349412A Contraceptive compositions containing cyclic urea and amide derivatives |
| 05/15/2002 | CN1349411A Compositions containing benzimidazolones and progestogens |
| 05/15/2002 | CN1349405A Use of antiprogestagens in combined therapy |
| 05/15/2002 | CN1348816A Dredging and childbirth promoting medicine powder |
| 05/15/2002 | CN1348810A Mastitis treating medicine |
| 05/15/2002 | CN1348798A Medicine prepn for treating lack of lactation after childbirth |
| 05/15/2002 | CN1348797A Healthy taxad composite for treating menalgia |
| 05/15/2002 | CN1348782A Externally applied medicine for treating cervical erosion and its prepn |
| 05/15/2002 | CN1348778A Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
| 05/15/2002 | CN1348769A Lubricating fluid for sexual intercourse |
| 05/15/2002 | CN1084630C Plaster for treating mastopathy |
| 05/15/2002 | CN1084629C Medicine for treating syphilis |
| 05/15/2002 | CN1084620C Medicine for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
| 05/14/2002 | US6388109 Hormone replacement therapy |
| 05/14/2002 | US6387899 Antiserotonine agents; antidepressants |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387629 Use of cathepsin S in the diagnosis and treatment of endometriosis |
| 05/14/2002 | CA2150162C New n-pyridyl carboxamides and derivatives thereof, preparation processes thereof and pharmaceutical compositions containing thereof |
| 05/14/2002 | CA2075876C Arylethylamines derivatives, process for their preparation and pharmaceutical compositions holding same |
| 05/14/2002 | CA2060815C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochr omanes |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036593A1 Indole derivatives as pde5-inhibitors |
| 05/10/2002 | WO2002036571A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | WO2002036171A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
| 05/10/2002 | WO2002036151A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | WO2002036144A1 Gnrh analogues for treatment of urinary incontinence |
| 05/10/2002 | WO2002036140A2 Use of a preparation of cimicifuga racemosa |
| 05/10/2002 | WO2002036127A2 Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001068677A3 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064236A3 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 05/10/2002 | WO2001038326A3 Imidazo-pyridine derivatives as ligands for gaba receptors |